Thank you to those that joined us on September 8th. In case you missed it, check out the full video recording, here:
Management of diabetes and related conditions represent one of the most complex and costly challenges in U.S. health care today, with over twenty million Americans diagnosed with Type 2 diabetes and approximately 1 in 5 health care dollars is spent caring for people with diabetes.
With a recent estimate that the U.S. spends approximately $4 billion in avoidable costs per year due to sub-optimal use of medicines, including poor medication adherence for patients with diabetes, it is clear that there are significant opportunities to optimize the use of those medications.
NEHI has worked to convene important stakeholders and experts in this field to develop recommendations for policies that would optimize the use of medication, improving care and lowering costs for patients with diabetes.
Featuring
Natalie Aboubechara, PharmD, Pharmacist Evidence Analyst & Strategist in Drug Information Service, Kaiser Permanente Office of Pharmacy Quality and Medication Safety
Natalie Aboubechara, PharmD, BCPS has been with Kaiser Permanente (KP) Drug Information Services since 2014. In her role as a Pharmacist Evidence Analyst and Strategist, her responsibilities include conducting clinical evidence reviews to support the formulary process, evaluating pipeline pharmaceuticals and forecasting market availability, cost, and impact on other available therapies while promoting evidence-based prescribing and cost-effective use of pharmaceuticals. Natalie received her Doctor of Pharmacy degree from the University of the Pacific Thomas J. Long School of Pharmacy in 2007. She completed a Managed Care Pharmacy Practice PGY1 Residency at KP Sacramento Medical Center and is board certified in Pharmacotherapy.
Murray Aitken, IMS Health Senior Vice President and Executive Director, IMS Institute for Healthcare Informatics.
Aitken is a renowned healthcare expert on addressing the challenges facing the global healthcare industry and prospects for improving patient outcomes, managing costs and maximizing access through better use of healthcare data and information. Established in 2011, The IMS Institute provides global policy setters and decision makers with objective, transformational insights into healthcare dynamics derived from granular analysis of information. Throughout his 15-year tenure at IMS Health, Aitken served in various roles responsible for healthcare insights, corporate strategy, and consulting and services. Prior, Aitken was a partner at McKinsey & Company in New Jersey and Los Angeles in the U.S. and in Seoul, Korea, covering a broad range of industries, including life sciences and consumer goods. He holds an MBA, with distinction from Harvard University and Masters of Commerce from the University of Auckland in New Zealand. A frequent speaker on the international healthcare industry circuit, Aitken’s perspectives are widely covered in the business/financial press, including The Wall Street Journal, The Financial Times, Fortune, Time, The Associated Press, Bloomberg Business, Reuters, CNBC as well as in local market publications across Europe, Asia and Latin America.
Kam L. Capoccia, PharmD, CDE, Associate Professor of Pharmacy Practice, Western New England University College of Pharmacy.
Capoccia received her B.S. degree in Pharmacy from the University of Connecticut and her Pharm.D. from the University of Colorado Health Sciences Center in Denver. She completed a general practice residency at the University of North Carolina Hospitals in Chapel Hill and a specialty residency in Primary Care at the University of Washington Family Medical Center in Seattle. Dr. Capoccia has served as faculty at the University of Washington School of Pharmacy and the University of Washington School of Medicine. She has also taught at the MEDEX Northwest Physician Assistant Program. Currently, she is an Associate Professor at Western New England University College of Pharmacy as well as the Residency Program Director for two community care practice residency programs. She is a Certified Diabetes Educator and is the director of a DEAP at the Western New England University College of Pharmacy and Big Y Foods, Inc Consultation and Wellness Center. She was a co-investigator for the ACCORD trial and has published two systemic reviews on medication taking in diabetes. Dr. Capoccia has spent more than 15 years working in collaborative practice agreements and has been a Board Certified Pharmacotherapy Specialist (BCPS) since 2000.
S. Lawrence Kocot, Principal, KPMG, LLP and National Leader, KPMG’s Center for Healthcare Regulatory Insight.
Larry is a Principal at KPMG, LLP and National Leader of KPMG’s Center for Healthcare Regulatory Insight. The center follows health care regulatory and policy trends driving health care transformation and industry convergence and the broader implications of operating in a more collaborative and integrated U.S. healthcare payment and delivery environment, matters relating to public health care programs, including Medicare and Medicaid. He has served as counsel to a wide range of corporations and associations on a variety of different matters, including investigations by the FTC, DOJ, SEC, and state attorneys general, as well as on qui tam and other litigation. Additionally, he has represented companies in audits and other disputes with the federal government and counseled organizations on the development and formation of accountable care organizations and other alternative payment arrangements.
Matthew Pickering, PharmD, RPh Associate Director of Research & Quality Strategies, Pharmacy Quality Alliance.
Dr. Matthew K. Pickering serves as the Associate Director of Research & Quality Strategies at the Pharmacy Quality Alliance (PQA). In this role, Dr. Pickering is responsible for coordinating research and demonstration project portfolios, including one of its flagship initiatives, ImmuSMART, a research project in the immunization space. Additionally, Dr. Pickering identifies needed studies to further validate the impact of PQA’s measures on improving patient care, reducing overall healthcare spending, and filling recognized gaps in performance measurement.
Dr. Pickering most recently completed a two-year Postdoctoral Fellowship at the University of Maryland, School of Pharmacy. In this capacity, Dr. Pickering utilized large clinical and claims datasets to conduct a series of research projects investigating Alzheimer’s disease and related dementia. Additionally, he also led a project leveraging large data assets for the derivation and testing of healthcare performance measures. Prior to joining the University of Maryland, Dr. Pickering received his PharmD from East Tennessee State University, and has also completed a Fellowship in Medical Communications and Drug Information at the Therapeutic Research Center. Dr. Pickering’s research activities include comparative effectiveness research, patient-centered outcomes research, and quality performance measurement.
